Evidence map›Paper›PMID 21480531›Full record

ArticleMacromolecular bioscience2011

Selective imaging and killing of cancer cells with protein-activated near-infrared fluorescing nanoparticles.

Parul Rungta, Yuriy P Bandera, Ryan D Roeder, Yangchun Li, William S Baldwin, Deepti Sharma, Michael G Sehorn, Igor Luzinov, Stephen H Foulger

Abstract read
In one paragraph

Article in Macromolecular bioscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Photodynamic nanomedicine in the treatment of solid tumors: perspectives and challenges.Journal of controlled release : official journal of the Controlled Release Society · 2013
    Review
  9. Nanotheranostics--a review of recent publications.International journal of nanomedicine · 2012
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Parul RungtaCenter for Optical Materials Science and Engineering Technologies, School of Materials Science and Engineering, Clemson University, Clemson, SC 29634-0971, USA.
Yuriy P Bandera
Ryan D Roeder
Yangchun Li
William S Baldwin
Deepti Sharma
Michael G Sehorn
Igor Luzinov
Stephen H Foulger
Clemson University · US

Funding

The Role of Cyp2b in Toxicant Metabolism and SensitivityR15ES017321 · NIEHS · CLEMSON UNIVERSITY · PI BALDWIN, WILLIAM S · 2009 to 2020
$1.3M
NIEHS NIH HHS R15 ES017321NIEHS NIH HHS R15-ES017321
6 · The paper itself

Abstract

We present a general approach for the selective imaging and killing of cancer cells using protein-activated near-infrared emitting and cytotoxic oxygen generating nanoparticles. Poly(propargyl acrylate) (PA) particles were surface modified through the copper-catalyzed azide/alkyne cycloaddition of azide-terminated indocyanine green (azICG), a near-infrared emitter, and poly(ethylene glycol) (azPEG) chains of various molecular weights. The placement of azICG onto the surface of the particles allowed for the chromophores to complex with bovine serum albumin when dispersed in PBS that resulted in an enhancement of the dye emission. In addition, the inclusion of azPEG with the chromophores onto the particle surface resulted in a synergistic ninefold enhancement of the fluorescence intensity, with azPEGs of increasing molecular weight amplifying the response. Human liver carcinoma cells (HepG2) overexpress albumin proteins and could be employed to activate the fluorescence of the nanoparticles. Preliminary PDT studies with HepG2 cells combined with the modified particles indicated that a minor exposure of 780 nm radiation resulted in a statistically significant reduction in cell growth.

Indexed as

Acrylic ResinsAzidesCell DeathCell Line, TumorFluorescent DyesHep G2 CellsHumansNanoparticlesNeoplasmsPhotosensitizing AgentsAcrylic ResinsAzidesFluorescent DyesPhotosensitizing Agents

Identifiers

PMID21480531
PMCPMC3678947
OpenAlexW2071132664

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.